Pharma Marketing
Masimo appoints Michelle Brennan as interim CEO following Joe Kiani's resignation amid a proxy battle with Politan Capital. This leadership transition may redefine the company s strategic direction in the medical device sector, impacting innovation and stakeholder relations.